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The effects of lead poisoning have been known
since ancient times. In 200 BC the Greek
physician Dioscorides observed that “lead
makes the mind give way.” Until the begin-
ning of the 20th century, lead poisoning was
viewed largely as an occupational disease of
adults. In the 1890s lead paint poisoning in
children was first recognized, and childhood
lead poisoning is now well documented and
persists as a major public health problem
throughout the world. Clinical features of
acute lead poisoning include abdominal pain
and neurologic symptoms of lead encephalopa-
thy including headache and confusion. In
severe cases renal failure and convulsions
can occur (Lewis 1997), and extremely high
levels may lead to coma and death (Meyer
et al. 2003b). Features of chronic lead poison-
ing include behavioral changes, nephritis, and
peripheral neuropathy [Lewis 1997; World
Health Organization (WHO) 1995]. Children
are more vulnerable to lead exposure for three
reasons: young children are more at risk of
ingesting environmental lead through normal
mouthing behaviors (Lanphear et al. 2002),
absorption from the gastrointestinal tract is
higher in children than adults (Ziegler et al.
1978), and the developing nervous system is
thought to be far more vulnerable to the toxic
effects of lead than the mature brain (Lidsky
and Schneider 2003).
Although there appears to be no dispute
about the effects of high levels of lead, there
has been uncertainty about the effects of low
levels of lead exposure on children’s health.
The debate has been particularly heated in the
United States (Ferber 2002; Wakeﬁeld 2002),
where data used to support laws and policies
relating to lead exposure have become the
subject of a number of lawsuits (Bellinger and
Dietrich 2002; Mushak 2002; Needleman
2002; Nelson 2002; O’Dowd 2002; Pinder
2002). A special issue of Archives of Clinical
Neuropsychology in 2001 was devoted to the
topic of intelligence quotient (IQ) and low-
level lead exposure in children. Five groups of
scientists were invited to reply to an article by
Kaufman (2001a) who posed the question
“Do low levels of lead produce IQ loss in chil-
dren?” (Brown 2001; Hebben 2001; Nation
and Gleaves 2001; Needleman and Bellinger
2001; Wasserman and Factor-Litvak 2001).
Kaufman argues that parental variables are far
more important to a child’s cognitive devel-
opment than is low-level lead exposure, and
that the loss of a few IQ points (if true) is
unlikely to have meaningful consequences for
society (Kaufman 2001a, 2001b). In contrast,
Needleman argues that lead-induced neuro-
toxicity has a causal role not only in cognitive
loss but also in the subsequent development of
juvenile delinquency and socially disruptive
behavior (Needleman 1995; Needleman and
Bellinger 2001; Needleman et al. 2002). These
two positions represent the opposite ends of
a spectrum of opinion on the relationship
between low-level lead exposure and child
development.
In contrast, debate in European countries
has been muted with an overriding feeling that
since the banning of leaded gasoline and lead-
containing paints, lead exposure no longer
poses a significant environmental threat to
health. Publication of a study by Canﬁeld and
colleagues in 2003 (Canﬁeld et al. 2003) chal-
lenged this view. Their study showed a dose-
dependent decline in cognitive function in a
cohort of children whose lifetime peak blood
levels never rose above the current World
Health Organization/Centers for Disease
Control and Prevention (WHO/CDC) blood
lead level of concern (10 µg/dL) and suggests
there is no safety margin at existing exposures.
Since its publication in April 2003, the
Canﬁeld study has been widely quoted and has
extended the debate beyond the United States.
With this in mind, the U.K. Department for
Environment, Food and Rural Affairs commis-
sioned the Medical Research Council Institute
for Environment and Health to examine in
detail the ﬁndings of Canﬁeld and colleagues
and to place their study within the context of
other recent developments, not just in the area
of low-level lead exposure but also in the wider
context of normal childhood development.
Our ﬁndings form the basis of this review.
Sources of Lead
Exposure/Current Blood
Lead Levels
The main sources of lead in children’s
environments are diet, lead-based paint in
older housing, lead in soil and dust from cont-
aminated leaded paint and gasoline, or past
and present mining and industrial activity
(Mielke 2002; Mielke and Reagan 1998).
Exposure from air and waterborne sources has
been greatly reduced with the introduction of
unleaded gasoline and the replacement of
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In the last decade children’s blood lead levels have fallen signiﬁcantly in a number of countries,
and current mean levels in developed countries are in the region of 3 µg/dL. Despite this reduc-
tion, childhood lead poisoning continues to be a major public health problem for certain at-risk
groups of children, and concerns remain over the effects of lead on intellectual development in
infants and children. The evidence for lowered cognitive ability in children exposed to lead
has come largely from prospective epidemiologic studies. The current World Health
Organization/Centers for Disease Control and Prevention blood level of concern reﬂects this and
stands at 10 µg/dL. However, a recent study on a cohort of children whose lifetime peak blood
levels were consistently < 10 µg/dL has extended the association of blood lead and intellectual
impairment to lower levels of lead exposure and suggests there is no safety margin at existing
exposures. Because of the importance of this ﬁnding, we reviewed this study in detail along with
other recent developments in the ﬁeld of low-level lead exposure and children’s cognitive develop-
ment. We conclude that these ﬁndings are important scientiﬁcally, and efforts should continue to
reduce childhood exposure. However, from a public health perspective, exposure to lead should be
seen within the many other risk factors impacting on normal childhood development, in particular
the inﬂuence of the learning environment itself. Current lead exposure accounts for a very small
amount of variance in cognitive ability (1–4%), whereas social and parenting factors account
for 40% or more. Key words: children, cognitive function, intellectual impairment, IQ, lead
exposure. Environ Health Perspect 112:987–994 (2004). doi:10.1289/ehp.6941 available via
http://dx.doi.org/ [Online 28 April 2004]lead water pipes and water tanks with nonlead
alternatives. However, lead in soil and dust
continues to be a major source of exposure.
Indoor ﬂoor dust accounts for approximately
50% of a young child’s total lead intake
[Institute for Environment and Health (IEH)
1998]. Although dust is a major source of lead
intake throughout the ﬁrst 1–2 years of child-
hood, lead-contaminated window sills in older
housing become an increasingly important
source of lead as children become mobile and
stand upright.
Blood lead levels peak in children at
around 2 years of age, and hand-to-mouth
behavior and pica (eating substances not nor-
mally eaten e.g., soil or paint chips) are signiﬁ-
cantly associated with elevated blood lead levels
(Lanphear et al. 2002). Children typically
ingest < 50 mg/day of soil on average (Stanek
and Calabrese 1995). However, in the case of
pica, this amount can be ≥ 5g   a day (Mielke
and Reagan 1998), and some children have
ingested 25–60 g during a single day (Calabrese
et al. 1997). Indeed, from the point of view of
risk assessment, Calabrese and colleagues urge
that soil pica be seen “as an expected, although
highly variable, activity in a normal population
of young children, rather than an unusual
activity in a small subset of the population.”
Soil abatement and paint hazard remediation
programs have attempted to reduce children’s
exposures to lead and other heavy metals, with
mixed outcomes (Elias and Gulson 2003;
Lanphear et al. 2003).
Children’s blood lead concentrations have
fallen substantially in a number of countries
in the last few decades, including the United
States, Australia, Mexico, Germany, Poland,
Sweden, and the United Kingdom (Delves
et al. 1996; IEH 1998; Jarosinska and Rogan
2003; Meyer et al. 2003a). By 1999 the geo-
metric mean blood lead for U.S. children
1–5 years of age had fallen from 15 µg/dL
in the late 1970s to 2.0 µg/dL. A survey
of 774 Swedish children over the period
1995–2001 showed blood lead levels had
stabilized at 2 µg/dL at 7–11 years of age
(Strömberg et al. 2003). In the United
Kingdom, blood lead levels of 584 children
measured during 1995 in the Avon Longi-
tudinal Study of Pregnancy and Childhood
(ALSPAC) showed a geometric mean of
3.44 µg/dL at 2.5 years of age (Golding et al.
1998). Despite these falls in blood lead levels,
childhood lead poisoning continues to be a
major public health problem for certain
groups of children, specifically low-income,
urban, African-American children in the
United States (Roberts et al. 2001), children
suffering from abuse and neglect (Chung
et al. 2001), children living in rural mining
communities (Lynch et al. 2000), and chil-
dren in developing countries (Falk 2003;
Fewtrell et al. 2004).
Lowering of exposure guideline levels
reﬂects concern over the growing body of evi-
dence that low levels of lead exposure have sub-
tle effects on the nervous system of children.
Since 1971 there have been four reductions
in the CDC guideline level above which chil-
dren are considered to have an elevated lead
level. This level currently stands at 10 µg/dL
(0.483 µmol/L). In 1997 the CDC estimated
that 4.4% of children in the United States
1–5 years of age have blood lead levels
≥ 10 µg/dL (Lynch et al. 2000). In a recent
report of blood lead levels in children
6 months to 5 years of age living in New
Orleans, Louisiana, USA, 29% had levels
≥ 10 µg/dL (Rabito et al. 2003). In Wuxi
City, China, 27% of children 1–5 years of age
had blood lead levels > 10 µg/dL (Gao et al.
2001), whereas in Johannesburg, South
Africa, the blood lead levels of 78% of school-
children ≥ 10 µg/dL (Mathee et al. 2002) and
in Dhaka, Bangladesh, 87% of children
4–12 years of age had blood lead levels
>1 0µ g/dL (Kaiser et al. 2001). In the United
Kingdom, large-scale blood lead monitoring
programs ceased in the late 1980s, and there
is a paucity of recent data on blood lead levels
in young children. The proportion of children
with blood lead levels > 10 µg/dL ranged from
0.74 to 5% according to recent reports from
three different regions of England (IEH 1998;
Lewendon et al. 2001; O’Donohoe et al.
1998), and there is growing concern that sig-
niﬁcant numbers of children under 5 years of
age remain at risk from lead exposure in the
United Kingdom (Grigg 2004).
Cross-Sectional Studies
Cross-sectional studies form part of a world-
wide effort to quantify the effects of lead
exposure in children. The main limitation of
such cross-sectional studies is that they meas-
ure blood lead at one speciﬁc time point only.
Because the half-life of lead in blood approxi-
mates that of the erythrocyte (approximately
35 days), it is primarily an indicator of recent
exposure. This is of particular importance
with lead exposure, as blood lead levels peak
in children at around 2 years of age.
We identiﬁed eight recent cross-sectional
studies looking at the relationship between
blood lead concentrations and children’s cogni-
tive abilities: the large U.S. National Health and
Nutrition Examination Survey (NHANES) III
(Lanphear et al. 2000) and seven studies from
six different countries [Croatia, Denmark, Saudi
Arabia, Mexico, Pakistan, and Taiwan (Al-Saleh
et al. 2001; Calderón et al. 2001; García-Vargas
et al. 2002; Nielsen et al. 2000; Prpic-Majic
et al. 2000; Rahman et al. 2002; Wang et al.
2002)]. All studies examined children 6 years
of age or older (range 6–16 years) but differed
in sample size (80–4,853) and the number of
confounders considered. Mean blood lead
levels ranged from 2.94 to 9.73 µg/dL. It was
unfortunate that the very large NHANES III
study (4,853 children) lacked data on two key
confounders: home environment and maternal
IQ. There was no consistent effect of blood
lead levels on cognitive function across these
studies, and taken together we believe they
add little to the current debate on low lead
exposure and its effect on cognition.
Prospective (Longitudinal)
Studies
The evidence for lowered intellectual and
cognitive ability in children exposed to lead
comes largely from prospective epidemiologic
studies of cohorts in Boston, Massachusetts,
USA; Cincinnati and Cleveland, Ohio, USA;
Port Pirie and Sydney, Australia; and
Yugoslavia (Factor-Litvak et al. 1999). A num-
ber of these studies are still ongoing. The main
focus of current debate centers on the difﬁcul-
ties of adjusting for confounders (covariables),
which include socioeconomic status (SES),
home environment, and genetic factors. SES is
measured in a number of ways that generally
involve an index derived from data on house-
hold income, parents’ education, employment
status, occupation, and home ownership.
Home environment is frequently measured
using the Home Observation for Measurement
of the Environment Inventory (HOME)
index. This reﬂects the quality and quantity of
emotional and cognitive stimulation and sup-
port in the home environment. The total score
is the sum of a number of items, each scored as
present (1) or absent (0), in various categories:
parental responsivity, acceptance of child, orga-
nization of home environment, provision of
play materials, parental involvement with
child, and variety of stimulation.
Longitudinal studies have many advantages
over cross-sectional studies: a) the time
sequence of events can be assessed, b) they can
provide information on a wide range of out-
comes, and c) there is reduced recall and selec-
tion bias compared with case–control studies.
Children’s intellectual capacities change with
time, and therefore age-speciﬁc tests must be
used (i.e., there is no single psychometric test
that can cover the entire age range of interest).
Unfortunately, in the five ongoing lead/IQ
studies identified, a variety of cognitive test
instruments were used, even for children of the
same age, and no two studies adjusted for the
same covariables. It is therefore not possible to
directly compare results between these studies.
The Yugoslavia Prospective Lead Study
was initiated in 1985. Pregnant women
(n = 1,502) living in two towns in Yugoslavia
were identiﬁed as having differing lead expo-
sures. One town is on the site of a lead smelter,
whereas the other (control) town lies 25 miles
to the south. Maternal blood lead was meas-
ured at midpregnancy and at delivery, and
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subsequent 6-month intervals. The report by
Wasserman and colleagues (2000) includes all
children (n = 390) having at least one assess-
ment of intellectual functioning at 3, 4, 5, or
7 years of age with complete data on all covari-
ates. Three normed and age-specific tests of
cognitive function were used. This review is a
reanalysis of data given in the authors’ full
1999 report, when the study was in its four-
teenth year (Factor-Litvak et al. 1999), and
examines whether there are critical time peri-
ods for the effects of lead exposure on IQ. Data
analysis was performed after grouping observa-
tions into three exposure–change categories.
An increase in postnatal blood lead was deﬁned
by a change of 50% or more relative to prena-
tal levels, with the postnatal period divided
into early (0–2 years of age) or late (2–7 years
of age). Average prenatal blood lead levels were
10 µg/dL (range 3–30 µg/dL) and average
postnatal levels at 2–7 years of age were
17.4 µg/dL (range 6.6–49 µg/dL). The wide
ranges are a reflection of pooling data from
children living in two towns with very different
exposure levels.
Both prenatal (p < 0.001) and postnatal
(p < 0.05) exposure were independently and
signiﬁcantly negatively correlated with IQ, and
no critical period of vulnerability was found. A
50% rise in prenatal blood lead levels was asso-
ciated with a 1.07-point loss in IQ score [95%
conﬁdence interval (CI), 0.6–1.53], whereas a
50% increase in postnatal blood lead relative to
prenatal levels was associated with a 2.82-point
IQ loss (95% CI, 0.52–4.91). Because the
analyses ﬁrst controlled for prenatal blood lead,
the postnatal change measure indicated a sub-
stantial change in exposure and was not a
reﬂection of whether the mean postnatal blood
lead was high or low. Covariates included in
the regression analysis were quality of the home
(HOME score); maternal age, intelligence, edu-
cation and ethnicity; birth weight; and sex.
Together these accounted for approximately
50% of the variance in IQ at 7 years of age; life-
time lead exposure accounted for 4.2% of the
variance (Factor-Litvak et al. 1999).
The report by Schnaas and colleagues
(2000) forms part of the Mexico City Pro-
spective Lead Study of 436 children born
after uncomplicated pregnancy. Intellectual
function was measured using the McCarthy
Scale, which provides a general index
of intellectual ability (General Cognitive
Index, GCI); subtests measure both cognitive
and motor function. Complete data were
obtained for 112 children followed at
6-month intervals between 3 and 5 years of
age. Prenatal blood lead measures were
recorded at intervals during pregnancy, at
delivery, and in cord blood. Average postnatal
blood lead levels were calculated for three time
periods: 6–18 months, 24–36 months, and
42–54 months. Geometric mean blood lead
concentrations were approximately 10 µg/dL
during the study period. Covariates used in
regression models were maternal IQ, child’s
sex, Apgar score at 5 min, birth weight, birth
rank order, maternal educational level and
IQ, and family SES (no details given). The
authors did not include HOME scores,
claiming that HOME scores are highly corre-
lated with maternal IQ and it was therefore
sufﬁcient to include only maternal IQ in the
model. The article is methodologically very
complex, with interactions measured between
many variables. The central finding is that
prenatal log-transformed blood lead levels are
not associated with intellectual function,
either within or between subjects, whereas
postnatal lead levels were signiﬁcantly corre-
lated with intellectual function. The strength
of the association between mean blood lead
(6–18 months) and GCI increases with age
up to 4 years of age, after which it becomes
less strong and decreases toward zero. This
study is one of only a few that attempts to
examine in detail the temporal pattern of the
association of lead levels and intellectual
function.
Tong et al. (2000) provide an update on
the 375 children born in the lead-smelting city
of Port Pirie, South Australia, who have been
followed from birth and had reached
11–13 years of age at the time of the study.
Previous studies of this cohort had shown that
blood lead concentration was negatively associ-
ated with cognitive performance, with girls
more sensitive to the effects of lead at 2, 4, and
7 years of age (Baghurst et al. 1992; Tong et al.
1996, 1998). Geometric mean blood lead lev-
els in this cohort increased from 8.3 µg/dL at
birth to 21.2 µg/dL at 2 years of age and
decreased to 7.9 µg/dL at 11–13 years of age.
This study explores whether there is any effect
modification between lead exposure and key
sociodemographic factors on IQ [measured
using the Wechsler Intelligence Scales for
Children-Revised (WISC-R) instrument] at
11–13 years of age. A large number of covari-
ates were measured. Sociodemographic factors
included sex, maternal IQ, HOME scores, and
SES (estimated by Daniel’s scale of prestige of
occupations in Australia). The cohort was
divided into three groups on the basis of life-
time average blood lead levels, with the lowest
group < 12 µg/dL and the highest group
>1 7µg/dL. The effect of sex became statisti-
cally insigniﬁcant at 11–13 years of age, and
the authors speculate that this may have been
due to attrition in numbers. (The original
cohort comprised 723 children.) The impact
of lead on IQ was more marked in children
with lower SES, although this became non-
signiﬁcant after adjusting for covariates. The
high-SES children performed significantly
better in arithmetic and vocabulary WISC-R
subscales than children from poor SES back-
grounds. Adjusted regression coefficients
showed boys lost 2.6 IQ points (95% CI,
2.9 to –8.0), whereas girls lost 7.4 IQ points
(95% CI, –1.7 to –13.1) for each 2.7-fold
increase in lifetime average blood lead level.
The study by Emory and colleagues (2003)
examined 79 mother–infant pairs who repre-
sented an independent sample drawn from a
larger population of more than 500 subjects in
an ongoing study of lead exposure. Mothers
came from an urban cohort of low-SES African
Americans in Atlanta, Georgia, USA, and their
infants were included in the study if they were
born after uneventful pregnancies. Maternal
blood lead was measured at 6 months’ gesta-
tion and before delivery and compared with
infant memory at 7 months, assessed by the
Fagan preferential-looking test. This study was
noteworthy for its use of more sensitive cali-
bration standards and continual verification
reference samples to increase confidence
in measuring very low blood lead levels
(< 5 µg/dL). Mean maternal blood lead was
0.72 ± 0.86 µg/dL. Umbilical blood lead was
measured, but no data were given in the arti-
cle. Infant Fagan scores were classiﬁed as low,
medium, or high risk of later mental retarda-
tion. Signiﬁcant negative correlations between
maternal blood lead and subsequent infant
Fagan ratings were reported. These differences
were not related to gestational age, birth
weight, or age at testing nor were they related
to mother’s education, although it was not
stated how this was measured. Overall, these
ﬁndings should be treated cautiously because
of the small numbers in the low- and high-risk
groupings, and the lack of detailed informa-
tion on confounders. The authors acknowl-
edge that their results require replication. This
is an ongoing study, and it will be of interest
to follow future publications.
The recent article by Canfield and
colleagues (2003) is part of this continuing
evidence base and relates to a cohort of 240 chil-
dren born between July 1994 and January
1995, living in Rochester, New York, USA, and
enrolled in the Rochester Longitudinal Lead
Study. This study population is a nested
cohort within a larger group of children and
their families who took part in a 24-month
randomized dust-control trial published in
1999 (Lanphear et al. 1999). The article by
Canﬁeld and colleagues reports on the results
of blood lead concentrations measured at 6,
12, 18, 24, 36, 48, and 60 months of age,
and IQ determined at 3 and 5 years of age
using the Stanford-Binet Intelligence Scale.
The relations between blood lead levels and
IQ were estimated with a variety of models,
with adjustments for nine prespeciﬁed covari-
ables: child’s sex, birth weight, iron status,
and home environment (HOME scale
conducted by face-to-face interview and
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R, personal communication); mother’s IQ,
years of education, race, and tobacco use dur-
ing pregnancy; and household income.
Adjusting for number of siblings and birth
order did not alter the model estimates or sig-
nificance levels, and these covariates were
therefore not included in the secondary analy-
ses (Canﬁeld R, personal communication).
The study reports a significant negative
association (p = 0.004) between blood lead lev-
els and IQ, with a 0.46-point decrease in IQ
for each microgram per deciliter increase in
lifetime average blood lead concentration (life-
time being equivalent to the child’s total expo-
sure over 3 or 5 years). For the subsample
of children whose maximal blood lead level
remained below 10 µg/dL over the 5 years, the
IQ loss associated with a given change in
blood lead level was greater. In these 101 chil-
dren, the study indicates a loss of 0.74 IQ
points for each microgram per deciliter
increase in lifetime blood concentration. The
authors suggest a nonlinear relationship
between children’s IQ scores and their blood
lead concentration, with larger associations at
lower lead concentrations. The importance of
this study is that it extends the association of
blood lead concentrations and intellectual
impairment to concentrations below the cur-
rent level of concern, which stands at 10 µg/dL
(0.483 µmol/L), and implies that there is no
safety margin at existing exposures.
To fully evaluate the results of the Canﬁeld
study, the experiences of their (nested) study
cohort within the original dust-control trial
must be considered. The Canﬁeld cohort com-
prised 240 children from a larger group of
276 children and their families taking part in
the dust-control trial. Families were eligible for
the dust-control trial if they lived in the city of
Rochester and had a child 5–7 months of age
at the time of the baseline visit. Participants
were identified using sequential lists of live
births from three urban hospitals, and families
were recruited by telephone. Families who
agreed to participate were visited by a study
team who carried out a baseline interview and
collected a venous blood sample from the
child. In addition, an experienced technician
collected and analyzed dust samples at various
indoor locations and measured lead content of
painted surfaces inside and outside the home.
This original cohort was randomly divided into
an intervention group (n = 140) and a control
group (n = 135). Families in the intervention
group received cleaning equipment and up to
eight visits by a dust-control advisor, although
the length of time between visits was not speci-
ﬁed. All families continued to be visited by the
study team at 6-month intervals for blood sam-
pling and environmental lead measurements
by a technician (blinded to intervention
status). In addition, at each of these home visits
an interviewer (also blinded) conducted a face-
to-face interview to identify, among other
things, the type and frequency of cleaning and
the last time cleaning was performed.
Over the 18-month dust-control study
period, there was a 2.6-fold increase in blood
lead levels in all children, but no difference in
blood lead levels by intervention status (geo-
metric mean level 2.85 µg/dL at 6 months,
7.55 µg/dL at 24 months). House dust lead
levels declined sharply in both the interven-
tion and control groups. Six months after the
ﬁrst baseline visit, dust lead levels in interior
window sills and on floors had decreased by
approximately 50% and continued to decline
at a slower rate over the following year. The
authors recognized several limitations of the
study, including sampling the same location
in each house, that is, the act of sampling
itself may have introduced an artiﬁcial decline
in dust lead levels. Another possibility was
that the act of sampling altered the cleaning
behavior of the control group families (the
Hawthorne effect). To examine whether the
regular visits and dust sampling introduced
such an effect, birth certiﬁcate data were used
to construct a matched negative-control group
of 236 children. Children were matched by
race, month of birth, and poverty level (meas-
ured by census block group characteristics). At
24 months of age the geometric mean blood
lead levels were 7.3 µg/dL (95% CI, 6.6–8.2)
in the intervention group, 7.8 µg/dL (95%
CI, 6.9–8.7) in the control group, and
7.3 µg/dL ± 2.2 µg/dL (CI not given) in the
matched negative controls. No Hawthorne
effect was apparent.
If it is assumed that the matched negative-
control group lived in homes with dust lead
levels equivalent to those found in the study
cohort before any interventions (baseline val-
ues), house dust lead levels do not appear to
correlate with blood lead levels in the study
children. This is not discussed in the 1999 arti-
cle by Lanphear et al. (1999) but highlights the
difﬁculties of accurately measuring lead levels
in the personal environment of young chil-
dren. It is interesting that data on house dust
lead levels were not included in a follow-up
report on dust control and blood lead levels
when these children attained 48 months of age
(Lanphear et al. 2000).
Canﬁeld et al. (2003) analyze the original
intervention and the control children as a sin-
gle population, and it is pertinent to ask
whether any of the interventions in the original
dust-control study may have affected blood
lead or IQ levels in their (nested) study group.
Although there was no signiﬁcant difference in
blood lead between the two groups from
12–24 months of age, the intervention group
mean blood levels were 5–7% lower than the
controls. If dust control had altered the
variability in blood lead levels, this could have
affected the power of the study to look at asso-
ciations with IQ. The second question to ask
is, “Could the up to eight extra visits from the
dust-control advisor have resulted in a more
stimulating learning environment for children
in the intervention group compared with con-
trols?” These families had extra visits by one of
two randomly assigned advisors, with the pro-
vision and replenishment of cleaning equip-
ment and supplies (brooms, dustpans, sponge
mops, buckets, gloves, and detergents). Mean
IQs of study children and their mothers were
below the national average, commensurate
with sample demographics. The IQs of the
children were normally distributed, whereas
IQs of the mothers were slightly skewed
because of a larger than expected number of
observations in the 70–75 range (Canﬁeld R,
personal communication). Because of low sam-
ple numbers no signiﬁcance should be attached
to this ﬁnding. If these interventions enhanced
the cognitive development of the children, they
would have resulted in a shift in the relation-
ship between IQ and blood lead levels, with a
higher IQ for a given lifetime blood lead level
in half of the study children. The effect of this
would be to reduce the overall contribution of
lead exposure to intellectual impairment.
Therefore, in the context of the results of the
Canfield study, the previous experiences of
their study cohort might have biased the study
ﬁndings toward the null, that is, attenuated the
association between blood lead level and IQ.
Nonlinear mixed models were analyzed
using the full range of blood lead values.
Figure 1 illustrates the unadjusted lifetime
average blood lead and IQ values. The authors
state that the cluster of 10 children with low
blood lead levels and high IQ “were not
unduly influential in the statistical models,”
and regression diagnostics did not identify any
outliers in the data. Secondary analyses (using
lifetime average blood lead levels) were carried
out on the basis of observations with IQ scores
< 110 (Canﬁeld R, personal communication).
For the full model this eliminated the 16 high-
est IQ scores. The overall linear regression
coefficient for the remaining subgroup was
–0.44 (p = 0.005), which is not significantly
different from the coefﬁcient of –0.46 for all
172 children. For the group of children with a
peak blood lead concentration < 10 µg/dL,
15 observations were eliminated by using the
IQ < 110 cutoff. In this case the linear regres-
sion coefﬁcient was –1.07 (p = 0.038), which
again is not significantly different from the
coefﬁcient of –1.37 for all children with a peak
blood lead < 10 µg/dL. However, after elimi-
nating these observations, the p-value decreased
from 0.05 to 0.08 in the quadratic model.
It would be of interest to know a)i f
removal of data from the 140 children in the
original dust-control intervention cohort alters
the semiparametric analysis relationship given
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of 10 children with high IQs (> 115) and low
blood lead levels (< 5 µg/dL) were assigned in
the original study. In addition, data from the
nine children with the highest blood lead levels
may have had a disproportionate inﬂuence on
the ﬁnal slope of the curve compared with sub-
jects clustered around the average blood lead
level, and further information on these nine
children would also be of interest.
Cognitive function was assessed using an
abbreviated Stanford-Binet Intelligence Scale
(version IV) at 3 and 5 years of age, with a dif-
ferent examiner administering the test at each
age. Results are expressed as the composite
score. However, this test may not have been
the most accurate measure of IQ for this
cohort. The Stanford-Binet is heavily weighted
on verbal skills and has been superseded by the
Wechsler scales for this reason. Anyone who
lacks English proficiency will do less well
in this test, and children were correctly
excluded from analysis if their parents lacked
English proﬁciency. Overall, the study children
had below-average Stanford-Binet scores
(89.8 ± 11.4). However, the standard method
for calculating the composite score excludes
subtests with a raw score of zero, and thus
overestimates IQ in those children achieving a
zero in any subtest. The Stanford-Binet IV
score at 3 years of age does not correlate well
with Wechsler Preschool and Primary Scale of
Intelligence (WPPSI) scores at 4–5 years of
age, but correlation is signiﬁcantly improved
by considering the number of subtests the
child did not perform at 3 years of age
(Grunau et al. 2000). The power of this study
would therefore have been increased if the chil-
dren had been assessed using the WPPSI test
or if the authors had considered the number of
zero-scored subtests in their analysis. However,
if it is assumed that children in the Canﬁeld
study achieving a zero in any subtest are those
with below-average IQs, the overall effect
would have been to introduce a differential
error in the estimates of IQ, that is, over-
estimating the IQ scores of children with
higher lead levels. This would have biased
(toward the null) the estimate of the slope of
the relationship between blood lead and IQ
and would have reduced the nonlinearity
observed in Figure 1.
In correspondence after publication of the
Canfield study, Bellinger and Needleman
(2003) reanalyzed data from their prospective
Boston cohort study, focusing on 48 children
whose blood lead levels never exceeded
10 µg/dL at birth, 6, 12, 18, 24, 57, or
120 months. The regression coefficient was
greater (–1.56) than that derived from analyses
of children with peak blood lead levels
>1 0µg/dL (–0.58), that is, their results repli-
cated those of Canfield and colleagues. This
reproducibility is of particular interest because
the Boston cohort (high SES, average IQ
of 105 at 2–4 years of age, mean blood lead
6.5 µg/dL at 2 years of age) was in many
respects very different from the Rochester
cohort (low SES, average IQ of 90 at 3 years of
age, mean blood lead 9.7 µg/dL at 2 years of
age). The authors conclude that residual con-
founding probably accounts for at least some
of the disparity between the regression coefﬁ-
cients above and below 10 µg/dL, and because
of this “the precise shape of the dose–effect
relation at lead levels below 10 µg/dL remains
uncertain” (Bellinger and Needleman 2003).
In summary, of the three most recent
longitudinal studies that measured prenatal lead
exposure (average blood lead ranging from 1 to
11.5 µg/dL), two found a negative association
with subsequent IQ, and one found no effect.
In contrast, all ﬁve recent longitudinal studies
that measured postnatal exposure (average
blood lead levels ranging from 6 to 44 µg/dL)
found significant associations with cognitive
development, and this association was main-
tained after adjusting for a range of covariates
including child’s sex and birth weight and
parental/maternal IQ and years of education.
The Port Pirie and Rochester studies considered
the widest range of confounding factors and
were the most robust methodologically. With
the report of Canﬁeld and colleagues and the
recalculation of the Boston cohort results, these
findings in nearly 1,300 children support an
association between childhood lead exposure
and subsequent cognitive impairment and
extend the range of concern to children with
lifetime average blood lead levels < 10 µg/dL.
Discussion
Epidemiologic studies are subject to two types
of error: systematic and random. Systematic
errors (or bias) are by far the most problematic
as they are generally not measured and they do
not decrease as the sample size increases. Key
sources of bias include those associated with
aspects of selection and the distortion of the
cause–effect relation by confounding. Reasons
for the controversy over the lead–IQ link
include a) the large number of confounders
that must be considered when measuring an
effect on children’s intelligence; and b) the
frequent finding that the more covariates
included in regression models, the smaller the
effect of blood lead on IQ becomes, although
it remains in the same direction (WHO
1995). The most important confounders are
SES, parental IQ, and the quality of the home
environment. Other factors associated with
both IQ and blood lead levels include sex,
nutritional status, and parental smoking
behavior.
Three studies shed light on the area of
confounding (Needleman and Bellinger 2001;
Tong and Lu 2001;Wasserman and Factor-
Litvak 2001). Blood lead levels have been neg-
atively and positively associated with SES.
Because of the sociodemographics and geogra-
phy of Boston, Massachusetts, USA, increased
prenatal lead levels were found in children of
higher SES, and after adjustment for covariates
the association of lead with IQ loss increased
(Needleman and Bellinger 2001). This effect
was also seen in the Yugoslavia prospective lead
study in which children living near a smelter
were from higher SES backgrounds than those
living in a nearby control town with lower
lead exposure (Wasserman and Factor-Litvak
2001). A study on the identification of con-
founders in the Port Pirie cohort study (Tong
and Lu 2001) found that the size of the rela-
tionship between blood lead levels and mean
IQ scores decreased by up to 40% when
adjustment was made for 4 confounders but by
less than 10% when a further 10 confounders
were added to the regression models. The four
main covariates were SES, quality of home
environment, maternal IQ, and parental smok-
ing behavior. The 10 extra confounders, which
had little effect individually, included age, sex,
birth weight, birth rank, maternal age, number
of siblings, and duration of breastfeeding
(Tong and Lu 2001).
Bellinger (2000) has argued that factors
such as SES and sex should not be viewed solely
as confounders but as effect modiﬁers as well.
Unlike confounding, effect modification is a
true characteristic of the association between an
exposure and its end point. An example is the
association between alcohol consumption and
blood pressure, which varies in size depending
on the modifying effects of the age, sex, and
smoking status of the individual. Using data
from the Boston prospective lead study,
Bellinger showed that children from the lower
half of the social class distribution demon-
strated a decrease in performance at lower
blood lead levels than children in the upper half
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Figure 1. Intelligence quotient as a function of life-
time average blood lead concentration. Data were
modiﬁed from Canﬁeld et al. (2003).of the distribution. However, this protective
effect of higher SES was lost in the group of
children with the highest cord blood lead levels.
The author’s hypothesis is that at a given expo-
sure level the magnitude of the estimated effect
varies depending on the individual’s location on
the social class continuum (Bellinger 2000).
This idea is not new. In 1984 Winneke and
Krämer (1984) showed the protective effects of
higher SES on visual-motor performance
deﬁcits in lead-exposed children and concluded, 
the common practice of merely removing the
effects of confounding factors, such as SES,
appears doubtful. . . . In addition, some of the
inconsistencies in this area of research might be
due to differential sampling of subgroups of lead-
exposed children characterized by different levels
of psychosocial adversity.
Intuitively, Bellinger’s hypothesis is very
attractive and provides a possible explanation
for the variability between ostensibly similar
studies. In the lead field in the past, study
results have been deemed right or wrong,
usually on the basis of how the issue of con-
founding was handled. If dose–effect relation-
ships are not independent of other host
characteristics, it will be necessary to model
three (or more)-way interactions. However,
most prospective studies are designed with only
enough statistical power to detect main effects
and do not have the power to detect effect
modiﬁcation in subgroups of the main cohort.
Bellinger urges a move away from broad, pop-
ulation-based cohorts toward a greater use of
focused sampling frames, which should include
adequate numbers within specific subgroups
(Bellinger 2000). The report on the Port Pirie
cohort at 11–13 years of age supports the
hypothesis that children from socially disad-
vantaged backgrounds are apparently more
sensitive to the effects of lead than children
from higher SES families (Tong et al. 2000).
The powerful inﬂuence of SES on develop-
mental outcome has been elegantly demon-
strated in a report on school-age children born
to mothers with heroin dependency (Ornoy
et al. 2001). The study followed children born
to mothers with heroin dependency raised at
home or adopted at a very young age. These
children were compared with groups of control
children with average SES, children raised in
families with a heroin-dependent father, or
children born in families with low SES and
high environmental deprivation. The children
with environmental deprivation or raised at
home by parents with heroin dependency had
the lowest intellectual achievements. The
adopted children had normal scores on the ver-
bal WISC-R and on the Bender test, as well as
normal reading and arithmetic skills, although
they had a higher rate of attention deficit
hyperactivity disorder than control children.
Ornoy later extended this work to include two
other high-risk cohorts: children born to
mothers with diabetes and children born pre-
maturely with low birth weights. Again he was
able to demonstrate that a good home environ-
ment had a strong influence on subsequent
intellectual abilities but not on motor skills or
attention span (Ornoy 2003).
Animal models using spatial learning in
rats have shown the protective effect of an
enriched environment on lead-induced neuro-
toxicity (Schneider et al. 2001). Of particular
relevance is a recent report on rats exposed to
low levels of lead during early development,
that is, from birth to weaning at day 21. This
exposure produced a lasting deﬁcit in spatial
learning that could be completely reversed by
raising the rats in an enriched environment
after weaning. This reversal was accompanied
by nerve growth factor gene induction and
recovery of deﬁcits in hippocampal glutamate
receptor gene expression (Guilarte et al. 2003).
Genetic predisposition can also affect
vulnerability to lead-induced neurotoxicity;
this area of research has recently been reviewed
by Lidsky and Schneider (2003). Three genes
are currently believed to play a role in lead neu-
rotoxicity: the ALAD gene, which codes for
δ-aminolevulinic acid dehydratase; the vitamin
D receptor (VDR) gene; and the hemochro-
matosis gene coding for a defective protein
known as HFE. There are two forms of the
ALAD protein, ALAD1 and ALAD2; lead has
a higher afﬁnity for ALAD2. Preliminary evi-
dence has shown adolescents with the ALAD1
phenotype are more resistant to the effects of
lead on behavior and attention than ALAD2
individuals. There are at least two alleles (b and
B) and three variants of the VDR genotype,
and among adults occupationally exposed to
lead, b individuals have higher lead levels in
blood and bone. Mutated HFE protein is
known to cause hemochromatosis, in which
large quantities of iron are deposited in internal
organs. Because lead can be incorporated into
processes requiring iron, polymorphisms in
HFE might be expected to influence lead
absorption. It is likely that future epidemiologic
studies will include analysis of ALAD status and
possibly other biomarkers.
Generally, no single epidemiologic study
should be treated as the sole source of convinc-
ing evidence. The weight of evidence for any
causal link comes when a number of studies
using similar or preferably different method-
ologies in different populations reveal the same
ﬁnding. In the low-level lead–IQ link, the bal-
ance has come down in favor of an association,
with the methodologically sound study by
Canfield et al. (2003) indicating that these
effects are seen at peak blood lead levels below
10 µg/dL. Having established a valid associa-
tion, the use of a number of the Bradford Hill
criteria can assist in making causal inferences:
temporal relationship (Does lead exposure
precede the effect on cognition?), biological
plausibility (Are there neurotoxic mechanisms
to explain the effect of lead on cognition?), and
biological gradient and strength (Is there a
dose–response relationship, and if so, how
strong is it?).
Evidence is increasing for a temporal rela-
tionship. The finding that 4–5 years of age
is the critical period for manifestation of ear-
lier (postnatal) lead exposure (Schnaas et al.
2000) might explain the wide variability in
effects reported in cross-sectional studies that
only looked at children 6 years of age or
older. Further support for the critical period
comes from the finding by Rogan et al.
(2001) that chelation therapy in lead-poi-
soned children has no beneficial effect when
given at 4–6 years of age.
Mechanistically, no unifying theory
explains the neurotoxicity of lead or how lead
might affect cognition. The ability of lead to
substitute for calcium is a common factor
underlying many of its toxic actions, including
apoptosis and inﬂuences on neurotransmitter
storage and release, second messengers, cere-
brovascular endothelial cells, and glial cells. A
variety of mechanisms may be important, and
these are summarized in recent reviews by De
Gennaro (2002) and Lidsky and Schneider
(2003). Lead activates calmodulin, calcineurin,
and protein kinase C at very low doses (Deng
and Poretz 2002; Kern and Audesirk 2000).
Glutamate receptors are thought to be involved
in mediation of learning and memory, and
changes in N-methyl-D-aspartate glutamate
receptor subunits are observed in animals that
show cognitive deﬁcits induced by exposure to
lead (Lau et al. 2002; Nihei and Guilarte
2001). Lead-induced decreases in hippocampal
neurotrophic factor gene expression in rats
can be reversed by raising the animals in an
enriched environment (Schneider et al. 2001).
Concerning dose–response relationships,
IQ tests are blunt measures of neurologic sta-
tus, and blood lead is at best only a crude index
of lead-induced neurotoxicity. However, a neg-
ative association has been found across groups
of children from a range of populations around
the world. Visual-motor tests and tests of
attention are designed to assess more limited
cognitive domains than IQ tests, and it is of
interest that more consistent decreases have
been reported for these measures in cross-
sectional studies (Al-Saleh et al. 2001;
Calderón et al. 2001; Walkowiak et al. 1998)
and prospective studies (Dietrich et al. 1993;
Tong et al. 1996; Wasserman et al. 1997). The
bluntness of IQ tests to measure cognitive
function is underlined by a study on ﬁve chil-
dren who underwent left temporal lobectomy
for epilepsy. Each patient experienced sig-
nificant language-related cognitive loss after
surgery, and these losses were clinically evident
in four of the ﬁve patients. However, IQ test-
ing alone did not reliably identify these deﬁcits.
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other four children showed increases in verbal
IQ (Dlugos et al. 1999).
It is clear that blood lead levels have fallen
signiﬁcantly over the last 40 years. During the
1970s, childhood blood lead concentrations of
40 µg/dL were not unusual. The available evi-
dence suggests that mean blood lead levels are
now in the range 2–4 µg/dL in the United
States and much of Europe. Despite this
reduction in lead exposure, it could be argued
that current baseline blood lead levels continue
to constitute a global public health risk, as
preindustrial humans are estimated to have had
100- to 1,000-fold lower blood lead levels than
the population of today (Owen and Flegal
1998). With the recent evidence demonstrat-
ing an inverse association between blood lead
levels and cognitive function in children
exposed to low levels of lead, there is no safety
margin at existing exposures. Clearly, efforts
must continue to minimize childhood expo-
sure. However, we would urge that these
efforts be seen in perspective. The magnitude
of the lead–IQ dose–response relationship is
small on a population basis and should be set
against the far greater combined effect of SES
status and quality of the caregiving environ-
ment. It has been argued that, instead of “chas-
ing after an ever-receding lead threshold,”
attention and funds should be focused on “the
more complex social ills that are associated
with continued lead exposure in a small seg-
ment of the population” (Gee and McKay
2002). Current lead exposure accounts for a
very small amount of variance in cognitive abil-
ity (1–4%), whereas covariates such as social
and parenting factors account for 40% or more
(Weiss 2000).
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